Sharp Memorial Hospital is a hospital in San Diego, California, in the United States. Opened in 1955, Sharp Memorial is Sharp HealthCare's largest hospital and the system's only designated Level II trauma center. Located in Serra Mesa, the hospital has 656 beds, including 48 for intensive-care services.

There are 656 beds in Sharp Memorial Hospital.

During the past decade, Sharp Memorial Hospital conducted 64 clinical trials. In the 10-year time frame, 64 clinical trials started and 63 clinical trials were completed, i.e. on average, 98.4% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 32 clinical trials were completed. i.e. 177.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sharp Memorial Hospital" #1 sponsor was "Abbott Medical Devices" with 13 trials, followed by "National Cancer Institute (NCI)" with 13 trials sponsored, "Alliance for Clinical Trials in Oncology" with 8 trials sponsored, "Boston Scientific Corporation" with 8 trials sponsored and "Bristol-Myers Squibb" with 8 trials sponsored. Other sponsors include 97 different institutions and companies that sponsored additional 71 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sharp Memorial Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 10 trials as a collaborator, "Thoratec Corporation" with 6 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 5 trials as a collaborator, "Canadian Cancer Trials Group" with 4 trials as a collaborator and "AstraZeneca" with 3 trials as a collaborator. Other collaborators include 65 different institutions and companies that were collaborators in the rest 61 trials.

According to Clinical.Site data, the most researched conditions in "Sharp Memorial Hospital" are "Breast Cancer" (8 trials), "Heart Failure" (5 trials), "Coronary Artery Disease" (4 trials), "Metastatic Melanoma" (4 trials) and "Prostate Cancer" (4 trials). Many other conditions were trialed in "Sharp Memorial Hospital" in a lesser frequency.

Most popular intervention types in "Sharp Memorial Hospital" are "Drug" (100 trials), "Device" (34 trials), "Other" (27 trials), "Biological" (17 trials) and "Procedure" (11 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (17 trials), "Quality-of-Life Assessment" (10 trials), "Nivolumab" (8 trials), "Ipilimumab" (7 trials) and "Laboratory Biomarker Analysis" (7 trials). Other intervention names were less common.

The vast majority of trials in "Sharp Memorial Hospital" are 128 trials for "All" genders, 14 trials for "Female" genders and 10 trials for "Male" genders.

Currently, there are NaN active trials in "Sharp Memorial Hospital". undefined are not yet recruiting, 12 are recruiting, 37 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 76 completed trials in Sharp Memorial Hospital, 1 suspended trials, and 21 terminated clinical trials to date.

Out of the total trials that were conducted in Sharp Memorial Hospital, 11 "Phase 1" clinical trials were conducted, 39 "Phase 2" clinical trials and 57 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 31 trials that are defined as “Not Applicable".